Isolator technology is emerging, albeit slowly, as an alternative to classified space in the manufacture of pharmaceutical and biological products. Isolators’ principal value is a reduction in the ...
A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback